The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Vetoryl 30 mg chewable tablets for dogs



Dechra Regulatory B.V.VPA22622/023/007

Main Information

Trade NameVetoryl 30 mg chewable tablets for dogs
Active SubstancesTrilostane
Dosage FormChewable tablet
Licence HolderDechra Regulatory B.V.
License Holder AddressHandelsweg 25
5531 AE Bladel
Netherlands
Licence NumberVPA22622/023/007

Group Information

ATC CodeQH02CA01 trilostane
Therapeutic ClassHormone
SpeciesDogs

Status

License statusAuthorised
Licence Issued28/06/2024
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back